Jean Wagnon

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal et al. · Proceedings of the National Academy of Sciences · 2002 · 459 citations · Full text

Psychotropic Medication, Affective Neuroscience, Psychopharmacology +24

Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.

C. Serradeil‐Le Gal, Jean Wagnon, Corinne Garcia et al. · Journal of Clinical Investigation · 1993 · 272 citations · Full text

Avp V2, Immunology, Pharmacotherapy +18

Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist

Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 207 citations · Full text

Unsymmetrical cyano-cuprates as reagents in substitution and addition reactions

Jean-Pierre Gorlier, Louis Hamon, J. Levisalles et al. · Journal of the Chemical Society Chemical Communications · 1973 · 61 citations

Asymmetric Catalysis, Chemical Engineering, Cross-coupling Reaction +13

[2.pi. + 6.pi.] Cycloaddition reactions between ligands coordinated to an iron atom

R. Davis, Tom A. Dodds, Tzong‐Hsiung Hseu et al. · Journal of the American Chemical Society · 1974 · 60 citations

Inorganic Chemistry, Molecular Sciences, Heterocyclic +14